InvestorsHub Logo
Followers 38
Posts 5020
Boards Moderated 1
Alias Born 04/25/2010

Re: pinhigh post# 216232

Saturday, 02/22/2020 11:32:28 AM

Saturday, February 22, 2020 11:32:28 AM

Post# of 329948

Maybe you missed it. Biel was granted FDA Full Body Clearance on Feb3


Judging from the trading activity and current share price, the market missed it as well. Outside a few flippers and some note holders punting shares, the market didn't care.

When a ticker can't generate significant interest on full body FDA approval, that's troubling. Likely news of signed deals will have the same lackluster impact.

Revenues and profits will be required to get this out of the abyss. With the CE mark pushed out until May, and shareholder updates indicating patience required to ink deals, and then lag time between the deals and execution of same.....well, looks like the significant increased sales needed to jump start the share price won't come until Q3 or later. Increasingly likely that 2020 will NOT (again) be the year of BIEL.

Of course, that pesky share structure just adds insult to injury. Penny a share? At the low end of 25 billion shares that's a valuation of $250 mil on sales that will struggle to hit $2 million in 2020. So a valuation of 125 times sales? Ludicrous. Sub-penny prices for many more months to come unfortunately.

Worse than that, the actual share count is somewhere in the 60 billion range by some accounts.....UGH. This will be looking at 2021. Give it until June - if still languishing at under half a cent, forget 2020 as the year of BIEL. Add it to the previous 'years of BIEL'....those puppies are adding up.